direct to your inbox Researchers have starting giving patients an antibody treatment that could offer immediate protection to people have been exposed to coronavirus to prevent them becoming seriously ill and dying.
The UCLH (University College London Hospitals NHS Trust) study is into whether the antibody developed by AstraZeneca will help patients when it would be too late to offer a vaccine.The University College London Hospitals NHS Trust (UCLH) is looking into the use of an antibody which could offer long-term protection to patients when it would be too late to offer a vaccine, as part of a new trial called Storm Chaser.Scientists have also begun a second clinical trial named Provent, to examine the use of the antibody for people who.